A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function - Vallet, Sonia; Pozzi, S.; Patel, K.; Vaghela, N.; Fulciniti, M. T.; Veiby, P.; Hideshima, T.; Santo, L.; Cirstea, D.; Scadden, D. T.; Anderson, K. C.; Raje, N. (Leukemia, 2011)
Gesehen am 01.12.2022